News
Lexicon Pharmaceuticals' Q1 2025 highlights include a transformative Novo Nordisk partnership, Phase 3 plans for pilavapadin in DPNP, and refocused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback